Literature DB >> 23349128

Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias.

Lilian H D van Tuyl1, Désirée van der Heijde, Dirk L Knol, Maarten Boers.   

Abstract

OBJECTIVES: To evaluate the difference between chronological and random sequence reading in a series of radiographs with 11 years' follow-up. In addition, the influence of the starting point and length of series was evaluated.
METHODS: Two experienced readers independently and repeatedly scored digitised radiographs of 62 patients at time points 0, 2, 5, 8 and 11 years of follow-up from the COBRA follow-up database according to the Sharp/van der Heijde method. A linear mixed model was fitted to the data.
RESULTS: Over 11 years the mean scores increased by 3.8 points per year. Compared to random reading, chronological reading resulted in a slightly increased progression rate of 0.4 points per year (p=0.008) and a lower standard error of the mean total progression rate of 0.30 (compared to 0.35 for random reading). Over 11 years, this results in a small difference in progression estimates of about five points, but a highly relevant difference of over 25% of patients needed in a study to find a difference in radiological outcome between two groups. Reading of short series, or series including a baseline radiograph, results in a significantly higher yearly progression rate compared to reading of long series, or series not including a baseline measurement.
CONCLUSIONS: Chronological reading of radiographs is preferred above random reading, due to decreased variability around the estimation of the progression rate; this increased efficiency translates into smaller sample sizes, or increased power to detect small differences. For studies with long-term follow-up, the same two readers should read all radiographs, including baseline.

Entities:  

Keywords:  Epidemiology; Outcomes research; Rheumatoid Arthritis

Mesh:

Year:  2013        PMID: 23349128     DOI: 10.1136/annrheumdis-2012-202876

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  Spondyloarthropathies: Sacroiliac joint radiographic progression - speed and determinants.

Authors:  Victoria Navarro-Compán; Pedro M Machado
Journal:  Nat Rev Rheumatol       Date:  2016-05-26       Impact factor: 20.543

2.  Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.

Authors:  Signe Møller-Bisgaard; Kim Hørslev-Petersen; Bo Ejbjerg; Merete Lund Hetland; Lykke Midtbøll Ørnbjerg; Daniel Glinatsi; Jakob Møller; Mikael Boesen; Robin Christensen; Kristian Stengaard-Pedersen; Ole Rintek Madsen; Bente Jensen; Jan Alexander Villadsen; Ellen-Margrethe Hauge; Philip Bennett; Oliver Hendricks; Karsten Asmussen; Marcin Kowalski; Hanne Lindegaard; Sabrina Mai Nielsen; Henning Bliddal; Niels Steen Krogh; Torkell Ellingsen; Agnete H Nielsen; Lone Balding; Anne Grethe Jurik; Henrik S Thomsen; Mikkel Østergaard
Journal:  JAMA       Date:  2019-02-05       Impact factor: 56.272

3.  Reliability of Magnetic Resonance Imaging (MRI) Scoring of the Metatarsophalangeal Joints of the Foot according to the Rheumatoid Arthritis MRI Score.

Authors:  Yousra J Dakkak; Xanthe M E Matthijssen; Désirée van der Heijde; Monique Reijnierse; Annette H M van der Helm-van Mil
Journal:  J Rheumatol       Date:  2019-09-15       Impact factor: 4.666

4.  Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.

Authors:  Fiona Maas; Anneke Spoorenberg; Elisabeth Brouwer; Reinhard Bos; Monique Efde; Rizwana N Chaudhry; Nic J G M Veeger; Peter M A van Ooijen; Rinze Wolf; Hendrika Bootsma; Eveline van der Veer; Suzanne Arends
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

5.  Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

Authors:  P H de Jong; J M Hazes; H K Han; M Huisman; D van Zeben; P A van der Lubbe; A H Gerards; B van Schaeybroeck; P B de Sonnaville; M V van Krugten; J J Luime; A E Weel
Journal:  Ann Rheum Dis       Date:  2014-05-01       Impact factor: 19.103

6.  Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis.

Authors:  Fiona Maas; Suzanne Arends; Elisabeth Brouwer; Hendrika Bootsma; Reinhard Bos; Freke R Wink; Anneke Spoorenberg
Journal:  Arthritis Res Ther       Date:  2017-04-26       Impact factor: 5.156

7.  Inter-rater reliability of the radiographic assessment of simple bone cysts.

Authors:  S Cho; R Yankanah; P Babyn; J Stimec; A S Doria; D Stephens; J G Wright
Journal:  J Child Orthop       Date:  2019-04-01       Impact factor: 1.548

8.  Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy.

Authors:  Ulf Sundin; Nina Paulshus Sundlisater; Anna-Birgitte Aga; Joseph Sexton; Lena Bugge Nordberg; Hilde Berner Hammer; Desirée van der Heijde; Tore K Kvien; Espen A Haavardsholm; Siri Lillegraven
Journal:  RMD Open       Date:  2021-02

9.  Does psychological stress in patients with clinically suspect arthralgia associate with subclinical inflammation and progression to inflammatory arthritis?

Authors:  Aleid C Boer; Robin M Ten Brinck; Andrea W M Evers; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2018-05-03       Impact factor: 5.156

10.  Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

Authors:  D F Ten Cate; J W G Jacobs; W A A Swen; J M W Hazes; M H de Jager; N M Basoski; C J Haagsma; J J Luime; A H Gerards
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.